Table 3.
Summary of interventions after Xen and MicroShunt implantations
| Xen (n = 41) | MicroShunt (n = 41) | p‐value | |
|---|---|---|---|
| Postoperative bleb management | 10 (24%) | 4 (10%) | 0.08 a |
| Bleb revision | 2 (5%) | 2 (5%) | 1.00 b |
| Bleb needling | 8 (20%) | 2 (5%) | 0.09 b |
| Other laser/surgery | |||
| Phacoemulsification§ | 6 (38%) | 4 (18%) | 0.27 b |
| MP‐TSCPC | 8 (20%) | 1 (2%) | 0.029 b |
| Trabecular micro‐bypass stent | 1 (2%) | 1 (2%) | 1.00 b |
| Glaucoma filtration surgery | 3 (7%) | 6 (15%) | 0.48 b |
| Glaucoma filtration device | 2 (5%) | 4 (10%) | 0.68 b |
| Trabeculectomy | 1 (2%) | 2 (5%) | 0.99 b |
Data are presented in no. (%).
MP‐TSCPC = MicroPulse transscleral cyclophotocoagulation.
a
Chi‐square test.
b
Fisher’s exact test. § % is corrected for phakic eyes only.